Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Cognitive Behavioral Strategies and Transcranial Magnetic Stimulation in Obsessive-Compulsive Disorder: Open Label Study [NA]
This open-label study at Duke evaluated cognitive-behavioral strategies in combination with transcranial magnetic stimulation for obsessive-…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD) [Phase 2]
Phase 2 trial evaluating transcranial magnetic stimulation as a treatment for obsessive-compulsive disorder has completed; results posted in…
-
FDA approval · 2017-01-20FDA Approved: PAROXETINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original application for Paroxetine, a generic selective serotonin reuptake inhibitor. The approval expa…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Attention Training for Childhood Obsessive Compulsive Disorder: An Open Case Series [Phase 1]
Clinical trial update reporting a Phase 1 open case series evaluating attention training for childhood obsessive-compulsive disorder. The st…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Attention Training for Childhood Obsessive Compulsive Disorder [NA]
A clinical trial studying attention training for childhood Obsessive Compulsive Disorder has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-01-04FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for PROZAC (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2017-01-04FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for fluoxetine from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2017-01-04FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for a generic fluoxetine hydrochloride product manufactured by Lannett Company, Inc.
-
FDA approval · 2017-01-04FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application from Aurobindo Pharma Limited to market a generic fluoxetine product.
-
FDA approval · 2017-01-04FDA Approved: FLUOXETINE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)
FDA approved a supplemental application for fluoxetine submitted by Saptalis Pharmaceuticals, LLC.
-
FDA approval · 2017-01-04FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for a generic Fluoxetine hydrochloride product from PAI Holdings dba PAI Pharma under ANDA 07601…
-
FDA label_change · 2016-12-28FDA Approved: FLUOXETINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for fluoxetine from Dr. Reddy's Laboratories Limited, indicating a labeling-related update to the ge…
-
FDA approval · 2016-12-27FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for fluoxetine hydrochloride from Lannett Company, Inc., resulting in approval of their generic fluo…
-
FDA approval · 2016-12-27FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluoxetine hydrochloride from PAI Holdings, LLC dba PAI Pharma.
-
FDA approval · 2016-12-27FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA granted a supplemental approval for a generic fluoxetine product from Aurobindo Pharma Limited under an ANDA.
-
FDA approval · 2016-12-27FDA Approved: FLUOXETINE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)
The FDA approved a supplemental application for fluoxetine (generic) from Saptalis Pharmaceuticals, LLC, for continued marketing under the a…
-
FDA approval · 2016-12-23FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sertraline hydrochloride (generic) manufactured by Mylan Pharmaceuticals Inc.; this represen…
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: Internet-delivered CBT for Adolescents With OCD: A Randomized Controlled Study [NA]
Karolinska Institutet reported the completion of a randomized controlled trial evaluating internet-delivered cognitive behavioral therapy fo…
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Adjunctive Glycine for Obsessive Compulsive Disorder [NA]
A completed clinical trial evaluated adjunctive glycine as an add-on treatment for obsessive-compulsive disorder. The study was conducted un…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: D-Cycloserine as an Adjunct to Internet-CBT for OCD [Phase 4]
Phase 4 study evaluating D-Cycloserine as an adjunct to internet-delivered CBT for obsessive-compulsive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Novel Deep Brain Stimulation in Ventral Capsule and Stratum for Refractory Obsessive-Compulsive Disorder [Phase 2, Phase 3]
Clinical trial update for a deep brain stimulation approach targeting the ventral capsule and striatum for refractory obsessive-compulsive d…
-
CLINICAL_TRIALS withdrawal · 2016-12-06Clinical Trial Update: China Refractory Obsessive-Compulsive Disorder Deep Brain Stimulation Study [Phase 2, Phase 3]
A China-based deep brain stimulation trial for refractory obsessive-compulsive disorder (Phase 2/3) has been withdrawn.
-
CLINICAL_TRIALS research · 2016-11-29Clinical Trial Update: Exposure and Response Prevention Therapy for Obsessive-compulsive Disorder [NA]
This entry notes a clinical trial update for exposure and response prevention therapy in obsessive-compulsive disorder, sponsored by Ruijin …
-
CLINICAL_TRIALS research · 2016-11-28Clinical Trial Update: iCBT for Children and Adolescents With Obsessive-compulsive Disorder [NA]
Update on a trial of Internet-delivered cognitive-behavioral therapy for children and adolescents with obsessive-compulsive disorder; curren…
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Internet-based Cognitive-behavior Therapy for Children With Obsessive-compulsive Disorder [NA]
A clinical trial conducted by Karolinska Institutet evaluating internet-based cognitive-behavior therapy for children with obsessive-compuls…